Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial
PLoS Clinical Trials · 2006
DOI: 10.1371/journal.pctr.0010026 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLoS Clinical Trials, 2006. Verfasst von Judith Hsia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, George Washington University, Washington, DC, United States of America. jhsia@mfa.gwu.edu. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, George Washington University, Washington, DC, United States of America. jhsia@mfa.gwu.edu
Zitieren
APA
Hsia, J., Manson, J. E., Kuller, L., Pettinger, M., Choe, J. H., Langer, R. D., Limacher, M., Oberman, A., Ockene, J., O'Sullivan, M. J., Robinson, J. G., & Women's Health Initiative Research (2006). Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial. PLoS Clinical Trials. https://doi.org/10.1371/journal.pctr.0010026
Vancouver
Hsia J, Manson JE, Kuller L, Pettinger M, Choe JH, Langer RD, et al. Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial. PLoS Clinical Trials. 2006. doi:10.1371/journal.pctr.0010026
BibTeX
@article{Hsia2006,
author = {Hsia, Judith and Manson, Joann E and Kuller, Lewis and Pettinger, Mary and Choe, John H and Langer, Robert D and Limacher, Marian and Oberman, Albert and Ockene, Judith and O'Sullivan, Mary Jo and Robinson, Jennifer G and Women's Health Initiative Research, Women's Health Initiative Research},
title = {Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial},
journal = {PLoS Clinical Trials},
year = {2006},
doi = {10.1371/journal.pctr.0010026}
}
EUVIMED